Atlas Trials

Cross-sectional Study for Identification and Description of Severe Asthma Patients

Clinical trial NCT02293265 · COMPLETED

Trial details

NCT number
NCT02293265
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Asthma
Start date
2014-12-01
Primary completion
2015-05-01
Enrollment
767

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.